Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.2K
Overview
51.2K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

2.6K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.6K
Cancer Vaccines01:30

Cancer Vaccines

936
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
936
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

1.7K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.7K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

83.4K
Overview
83.4K
Humoral Immune Responses01:36

Humoral Immune Responses

83.3K
Overview
83.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BTK drives neutrophil activation for sterilizing antifungal immunity.

The Journal of clinical investigation·2024
Same author

Vaccination against neoantigens induced in cross-priming cDC1 in vivo.

Cancer immunology, immunotherapy : CII·2024
Same author

Remodeling of Stromal Immune Microenvironment by Urolithin A Improves Survival with Immune Checkpoint Blockade in Pancreatic Cancer.

Cancer research communications·2023
Same author

Impact of stereopure chimeric backbone chemistries on the potency and durability of gene silencing by RNA interference.

Nucleic acids research·2023
Same author

Mesothelin-targeting T cells bearing a novel T cell receptor fusion construct (TRuC) exhibit potent antitumor efficacy against solid tumors.

Oncoimmunology·2023
Same author

Author Correction: Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity.

Nature communications·2021

Related Experiment Video

Updated: Jan 10, 2026

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.5K

Vaccination Against Pathogens Targeting Cell-Derived Cryptic Antigens.

Emily S Clark1, Greta Garrido1, Agata Levay1

  • 1Department of Microbiology and Immunology.

The Journal of Infectious Diseases
|November 24, 2025
PubMed
Summary
This summary is machine-generated.

This study reveals a novel vaccination strategy targeting pathogen-infected cells by exploiting reduced TAP expression. This approach sensitizes infected cells to host-derived antigens, offering a universal vaccine prototype against tumors and infections like HIV, CMV, and EBV.

Keywords:
CD8+ T cellsHIVTAP downregulation–induced antigensantibody targetingpeptide transporter TAPsiRNA

More Related Videos

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

10.3K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.2K

Related Experiment Videos

Last Updated: Jan 10, 2026

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.5K
In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

10.3K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.2K

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases

Background:

  • CD8+ T cell responses are crucial for combating viral infections like HIV, CMV, and EBV.
  • Developing effective T cell vaccines is hindered by challenges in identifying pathogen antigens, antigenic variability, and immune dysfunction.

Purpose of the Study:

  • To test if pathogen-infected cells with downregulated TAP expression can be targeted by vaccines against host-derived antigens.
  • To develop a universal vaccine strategy for tumors and pathogen-infected cells.

Main Methods:

  • Investigated the presentation of cryptic epitopes in cells with downregulated TAP (transporter associated with antigen processing).
  • Utilized peripheral blood mononuclear cells (PBMC) to generate CD8+ T cells recognizing TAP-downregulated epitopes.
  • Assessed the recognition and depletion of TAP-low infected cells (CMV, EBV, HIV) by T cells.

Main Results:

  • Downregulation of TAP in infected cells (CMV, EBV, HIV) led to the presentation of a non-mutated cryptic epitope.
  • CD8+ T cells recognizing multiple TAP-downregulation-induced epitopes effectively targeted and depleted TAP-low infected cells.
  • T cell activation markers were expressed upon recognition of infected cells.

Conclusions:

  • A universal vaccine prototype can be developed by targeting host-derived antigens presented by TAP-low infected cells.
  • This strategy bypasses the need for identifying pathogen-specific antigens, overcoming limitations of antigenic heterogeneity and immune dysfunction.
  • Potential applications include vaccination against tumors and persistent viral infections like HIV, CMV, and EBV.